[1]
Abdelaziz M. Hussein et al. 2021. Investigation on the Effects of GLP1 analog and SGLT2 inhibitor against Diabetic Cardiomyopathy in Type 2 Diabetic Rats: Possible Underlying Mechanisms. Highlights on Medicine and Medical Research Vol. 9. (May 2021), 1–20. DOI:https://doi.org/10.9734/bpi/hmmr/v9/8259D.